Paper Details

Paper Title

Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia.

Paper Journal Title

Chest

Paper Citation Count

Paper Publication Year

2022

Bio Mention

COVID-19, Hypoxemia, OFDs, Oxygen, acute lung injury, hypoxemia, hypoxemic lung dysfunction, oxygen, patient, patients

Mesh Descriptor

Acute Lung Injury, Adult, COVID-19, Clinical Trials as Topic, Humans, Hypoxia, Outcome Assessment, Health Care, Oxygen, Pandemics

Author Name	Affiliation
Ari Moskowitz	Montefiore Medical Center
Matthew S Shotwell	Vanderbilt University Medical Center
Kevin W Gibbs	Wake Forest University
Michelle S Harkins	University of New Mexico
Michelle S Harkins	University of New Mexico
Yves Rosenberg	and Blood Institute
James F Troendle	and Blood Institute
Lisa H Merck	Virginia Commonwealth University
Daniel Clark Files	Wake Forest University
Marjolein de Wit	Virginia Commonwealth University
Kristin Hudock	University of Cincinnati
Boyd Taylor Thompson	Massachusetts General Hospital
Michelle N Gong	Montefiore Medical Center
Adit A Ginde	University of Colorado School of Medicine
David J Douin	University of Colorado School of Medicine
Samuel M Brown	Intermountain Medical Center
Eileen Rubin	ARDS Foundation
Meghan Morrison Joly	Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Li Wang	Vanderbilt University Medical Center
Christopher J Lindsell	Vanderbilt University Medical Center
Gordon R Bernard	Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Matthew W Semler	Vanderbilt University Medical Center
Sean P Collins	Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, TN Veterans Affairs Tennessee Valley Healthcare System, Education and Clinical Center (GRECC)
Wesley H Self	Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center

Column Actions